Pharmaceutical

Oxford BioTherapeutics and Roche link on antibody cancer treatments

OBT has entered a multi-year partnership with Roche to discover antibody-based therapeutics for cancer treatment.

Mar 21, 2025 - 06:00
Oxford BioTherapeutics and Roche link on antibody cancer treatments
OBT has entered a multi-year partnership with Roche to discover antibody-based therapeutics for cancer treatment.
Read the original article

Tags:

Previous Article

Pfizer sells 7.3% stake in Haleon for $3.3bn

Next Article

Blood cancers dominate CAR-T pipeline

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

‘We went from almost no lockdowns to daily lockdowns’: The mental health crisis inside California women’s prisons

‘We went from almost no lockdowns to daily lockdowns’: ...

Apr 29, 2023

Opinion: Does food as medicine help patients with diabetes? Here’s what a new clinical trial says

Opinion: Does food as medicine help patients with diabe...

Dec 27, 2023

Specialised Therapeutics partners with Treeway to license ALS drug

Specialised Therapeutics partners with Treeway to licen...

Aug 28, 2023